Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective
Lists
Only you see this
Abstract
Despite an age-independent stable frequency of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter hypermethylation, tumors in this age group largely lack prognostically favorable markers established in younger glioblastoma patients, which likely contributes to the overall worse prognosis of elderly patients. However, the survival differences hint at fundamental further differences among malignant gliomas of different age groups.
BibTeX
@inproceedings{wiestler2013malignant,
author = {Benedikt Wiestler and Rainer Claus and Sabine Hartlieb and Maximilian G. Schliesser and Elisa K. Weiß and Thomas Hielscher and Michael Platten and L M Dittmann and Christoph Meisner and Jörg Felsberg and Caroline Happold and Matthias Simon and Guido Nikkhah and Kirsten Papsdorf and Jörg Steinbach and Michael Sabel and Christian Grimm and Dieter Weichenhan and Björn Tews and Guido Reifenberger and David Capper and Wolfram Müller and Christoph Plass and Michael Weller and Wolfgang Wick and for the Neuro-oncology Working Group (NOA) of the German Cancer Society},
title = {{Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective}},
booktitle = {Neuro-Oncology},
year = {2013},
doi = {10.1093/neuonc/not043},
}Loading related content...